Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability

Latrepirdine/Dimebon is a small-molecule compound with attributed neurocognitive-enhancing activities, which has recently been tested in clinical trials for the treatment of Alzheimer's and Huntington's disease. Latrepirdine has been suggested to be a neuroprotective agent that increases m...

Descripción completa

Detalles Bibliográficos
Autores principales: Weisová, P, Alvarez, S P, Kilbride, S M, Anilkumar, U, Baumann, B, Jordán, J, Bernas, T, Huber, H J, Düssmann, H, Prehn, J H M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818013/
https://www.ncbi.nlm.nih.gov/pubmed/24150226
http://dx.doi.org/10.1038/tp.2013.92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818013/
https://www.ncbi.nlm.nih.gov/pubmed/24150226
http://dx.doi.org/10.1038/tp.2013.92

Ejemplares similares